Concepedia

Author

N. George Mikhaeel

Guy's and St Thomas' NHS Foundation TrustORCID

Also Known As

George Mikhaeel, N G. Mikhaeel, N George Mikhaeel, N. G. Mikhaeel, N. George Mikhaeel, N. Mikhaeel, N.G. Mikhaeel, Nabegh George Mikhaeel, Pam McKay

103

Publications

6.2K

Citations

33

H-Index

41

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation TrustKing's College LondonSt Thomas' HospitalRigshospitaletKings Health Partners
NG

About

N. George Mikhaeel is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, radiology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

2K

2

Health Sciences

12

13

1.4K

3

Pathology

9

9

880

4

Biostatistics

1

1

144

5

Clinical Sciences

1

1

71

N. George Mikhaeel

×

35

Publications

5.4K

Citations

27

H-Index

YearCitations

Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu,

Journal of Clinical Oncology

2014

1.6K

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Lena Specht, Joachim Yahalom, Tim Illidge,

International Journal of Radiation Oncology*Biology*Physics

2013

567

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma

N. George Mikhaeel, Martin Hutchings, Paul Fields,

Annals of Oncology

2005

405

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma

Martin Hutchings, N. George Mikhaeel, Paul Fields,

Annals of Oncology

2005

326

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL

N. George Mikhaeel, Daniel Smith, Joel Dunn,

European Journal of Nuclear Medicine and Molecular Imaging

2016

303

18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT

N. George Mikhaeel, A.R. Timothy, M. J. OʼDoherty,

Leukemia & lymphoma/Leukemia and lymphoma

2000

247

PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement

Anjum Khan, Sally F. Barrington, N. George Mikhaeel,

Blood

2013

234

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma

Hajira Ilyas, N. George Mikhaeel, Joel Dunn,

European Journal of Nuclear Medicine and Molecular Imaging

2018

144

Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

N. George Mikhaeel, Martijn W. Heymans, Jakoba J. Eertink,

Journal of Clinical Oncology

2022

135

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Tarec Christoffer El‐Galaly, Chan Y. Cheah, Mette Dahl Bendtsen,

European Journal of Cancer

2018

130

Page 1